AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pyxis Oncology, Inc. Director's Dealing 2024

Mar 28, 2024

33976_dirs_2024-03-28_b2abfea7-6447-4c09-9d50-ef71e515595b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2024-03-26

Reporting Person: HUMPHREY RACHEL (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-26	Common Stock	A	38741	—	Acquired	96805	Direct

Footnotes

F1: Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.